Skip to main content
. 2021 Jul 28;9:713258. doi: 10.3389/fpubh.2021.713258

Table 4.

Basic analysis results.

Project Cumulative cost(¥) Cumulative effectiveness (QALYs) Incremental cost Incremental effectiveness ICER (¥/QALY)
BUD/FORa 173,030.05 7.73
FF/UMEC/VIb 199,765.55 8.54 26,735.50 0.81 33,006.80
a

Fluticasone/umeclidinium/vilanterol triple combination.

b

Budesonide/formoterol double combination.